Warning letter
Sunshine Mills, Inc: warning letter of Mar 7, 2022
FDA warning letter 618141 · Human and Animal Food East V Compliance Branch (HAFE5-CB)
Key facts
| Reference number | 618141 |
|---|---|
| Company | Sunshine Mills, Inc |
| Subject | CGMP/Animal Food/Adulterated |
| Issue date | Mar 7, 2022 |
| Posted date | Apr 18, 2022 |
| Issuing office | Human and Animal Food East V Compliance Branch (HAFE5-CB) |
| Product type | Veterinary |
| CFR sections cited | 507, 507.1(a)(1)(ii), 507.19(a), 507.22(a)(4)(iii), 507.34(a)(1), 507.42(a)(2)(ii), 507.42(a)(2)(iii), 507.42(a), 507.42(a)(1)(i) |
| Inspection city | Tupelo |
| Inspection ZIP | 38801 |
| Inspection start date | Jul 19, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: